France-based EOS imaging has installed its system at the hospital of the Chinese University of Hong Kong (CUHK) in Hong Kong, the firm’s first installation in the region.
Established in 1982, CUHK’s orthopaedics department provides services in patient care, research and education.
EOS imaging CEO Marie Meynadier said: "The Chinese University of Hong Kong is ranked as a leading university for orthopaedic care in Asia and we are thrilled by their decision to adopt EOS for their diagnosis, planning and control imaging.
"This new installation will strengthen our growing presence in the important Asia-Pacific market where we are investing to deploy our technology."
Installed at the hospitals’ department of orthopaedics and traumatology, the EOS system offers full-body stereoradiographic images of patients in 2D and 3D with 50%-85% less radiation dose and 95% less than basic CT scans.
The new EOS Micro Dose option, which is approved by US Food and Drug Administration, allows better achievement of as low as reasonably available (ALARA) principle by bringing paediatric spine follow up exams at the dose level.
EOS imaging develops and markets EOS and associated solutions in 47 countries, including the US, Japan and European Union (EU).
Based in Paris, the group has four subsidiaries, with offices in Besançon, France, Cambridge, US, Montreal, Canada and Frankfurt, Germany. It also carries out operations in Singapore. The group reported consolidated revenue of €20.1m in 2014.